Together with Drs. Bin Zhang and Jose Silva, we have studied pseudo-temporal aspects to chemoresistance in triple-negative breast cancer cells, and identified EGFR/HER2 inhibition as effective strategy during mid-neoadjuvant chemotherapy. (https://www.cell.com/iscience/fulltext/S2589-0042(23)00141-4)